In today’s session Clorox Co (CLX) recorded an unusually high (561) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the October, 2016 put, expecting serious CLX decrease. With 561 contracts traded and 10934 open interest for the Oct, 16 contract, it seems this is a quite bearish bet. The option with symbol: CLX161021P00120000 closed last at: $1 or 42.9% up. About 273,288 shares traded hands. Clorox Co (NYSE:CLX) has declined 3.21% since March 3, 2016 and is downtrending. It has underperformed by 11.55% the S&P500.
Analysts await Clorox Co (NYSE:CLX) to report earnings on November, 7. They expect $1.42 earnings per share, up 7.58% or $0.10 from last year’s $1.32 per share. CLX’s profit will be $183.29 million for 21.70 P/E if the $1.42 EPS becomes a reality. After $1.26 actual earnings per share reported by Clorox Co for the previous quarter, Wall Street now forecasts 12.70% EPS growth.
Clorox Co (NYSE:CLX) Ratings Coverage
Out of 9 analysts covering The Clorox Company (NYSE:CLX), 1 rate it a “Buy”, 4 “Sell”, while 4 “Hold”. This means 11% are positive. The Clorox Company has been the topic of 17 analyst reports since August 5, 2015 according to StockzIntelligence Inc. Atlantic Securities upgraded Clorox Co (NYSE:CLX) on Friday, September 16 to “Buy” rating. Barclays Capital maintained the stock with “Underweight” rating in Monday, March 21 report. The firm earned “Sell” rating on Thursday, August 4 by UBS. On Wednesday, October 7 the stock rating was maintained by Barclays Capital with “Underweight”. The firm has “Buy” rating by Sterne Agee CRT given on Tuesday, July 21. The stock has “Hold” rating given by Deutsche Bank on Tuesday, November 3. The company was initiated on Tuesday, June 14 by Atlantic Securities. The company was maintained on Tuesday, November 3 by RBC Capital Markets. The stock has “Neutral” rating given by Sterne Agee CRT on Friday, February 26. UBS maintained the stock with “Sell” rating in Tuesday, November 3 report.
According to Zacks Investment Research, “Clorox Company’s business operations, represented by the aggregate of its U.S. Household Products and Canada, U.S. Specialty Products and International segments, include the production and marketing of non-durable consumer products sold primarily through grocery and other retail stores.”
Insitutional Activity: The institutional sentiment decreased to 0.98 in 2016 Q2. Its down 0.12, from 1.1 in 2016Q1. The ratio dropped, as 66 funds sold all Clorox Co shares owned while 246 reduced positions. 49 funds bought stakes while 256 increased positions. They now own 87.29 million shares or 6.63% less from 93.49 million shares in 2016Q1.
Oxbow Advsrs Lc reported 3,570 shares or 0.07% of all its holdings. America First Advisors Ltd Liability has 6.16% invested in the company for 106,650 shares. Riverpoint Cap Mgmt Ltd Limited Liability Company has 0.08% invested in the company for 6,571 shares. Moreover, Checchi Advisers Lc has 0.01% invested in Clorox Co (NYSE:CLX) for 820 shares. Capstone Asset Mngmt Communication last reported 0.21% of its portfolio in the stock. Washington Trust Financial Bank holds 0.02% of its portfolio in Clorox Co (NYSE:CLX) for 500 shares. Duncker Streett & Inc has 0.12% invested in the company for 2,400 shares. Northwest Inv Counselors Ltd Limited Liability Company holds 15,447 shares or 1.17% of its portfolio. First Interstate Bancorp, a Montana-based fund reported 366 shares. Texas Permanent School Fund holds 0.08% of its portfolio in Clorox Co (NYSE:CLX) for 41,964 shares. Mechanics Bancorp Department, a California-based fund reported 14,779 shares. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Investment Management Corporation accumulated 127,500 shares or 0.2% of the stock. Kanaly Tru last reported 662 shares in the company. Moreover, Los Angeles And Equity has 0.64% invested in Clorox Co (NYSE:CLX) for 543,378 shares. Allsquare Wealth Mngmt Limited Liability Corp accumulated 0.01% or 50 shares.
Insider Transactions: Since May 10, 2016, the stock had 0 insider buys, and 5 sales for $7.59 million net activity. Vlahos Nikolaos A also sold $123,093 worth of Clorox Co (NYSE:CLX) on Wednesday, August 10. STEIN LAURA had sold 38,882 shares worth $5.12 million on Friday, September 2. The insider Willoughby Dawn C sold $1.39M. $673,517 worth of shares were sold by Balousek Jon M on Monday, August 29.
The Clorox Company is a manufacturer and marketer of consumer and professional products. The company has a market cap of $15.91 billion. The Firm sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. It has a 25.03 P/E ratio. The Firm operates through four divisions: Cleaning, Household, Lifestyle and International.
CLX Company Profile
The Clorox Company, incorporated on September 5, 1986, is a maker and marketer of consumer and professional products. The Firm sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Firm operates through four divisions: Cleaning, Household, Lifestyle and International. The Firm markets some of the consumer brand names, including namesake bleach and cleaning products, Pine-Sol cleaners, Liquid-Plumr clog removers, Poett home care products, Fresh Step cat litter, Glad bags, wraps and containers, Kingsford charcoal, Hidden Valley dressings and sauces, Brita water-filtration products and Burt’s Bees natural personal care products. The Firm also markets brands for professional services, including Clorox Healthcare and Clorox Commercial Solutions. The Firm makes products in approximately 10 countries and markets them in over 100 countries.
More news for Clorox Co (NYSE:CLX) were recently published by: Investorplace.com, which released: “Stocks to Buy: Colgate-Palmolive Corporation & Clorox Co Shine (CL, CLX)” on October 05, 2016. Fool.com‘s article titled: “Is The Clorox Company Stock Too Expensive?” and published on September 29, 2016 is yet another important article.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.